A carregar...

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

PURPOSE: The standard treatment for relapsed diffuse large B-cell lymphoma (DLBCL) is salvage chemotherapy followed by high-dose therapy and autologous stem-cell transplantation (ASCT). The impact of maintenance rituximab after ASCT is not known. PATIENTS AND METHODS: In total, 477 patients with CD2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gisselbrecht, Christian, Schmitz, Norbert, Mounier, Nicolas, Singh Gill, Devinder, Linch, David C., Trneny, Marek, Bosly, Andre, Milpied, Noel J., Radford, John, Ketterer, Nicolas, Shpilberg, Ofer, Dührsen, Ulrich, Hagberg, Hans, Ma, David D., Viardot, Andreas, Lowenthal, Ray, Brière, Josette, Salles, Gilles, Moskowitz, Craig H., Glass, Bertram
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646314/
https://ncbi.nlm.nih.gov/pubmed/23091101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.41.9416
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!